Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Preaxia Health Care Payment Systems (PAXH) EBIT (2019 - 2025)

Preaxia Health Care Payment Systems (PAXH) has disclosed EBIT for 7 consecutive years, with -$875203.0 as the latest value for Q3 2025.

  • Quarterly EBIT fell 18815.13% to -$875203.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$906959.0 through Aug 2025, down 1336.04% year-over-year, with the annual reading at -$152124.0 for FY2025, 52.97% down from the prior year.
  • EBIT hit -$875203.0 in Q3 2025 for Preaxia Health Care Payment Systems, down from -$13463.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$4611.0 in Q2 2024 to a low of -$875203.0 in Q3 2025.
  • Historically, EBIT has averaged -$79125.4 across 5 years, with a median of -$40317.0 in 2021.
  • Biggest five-year swings in EBIT: soared 88.69% in 2024 and later crashed 18815.13% in 2025.
  • Year by year, EBIT stood at -$43655.0 in 2021, then dropped by 3.29% to -$45092.0 in 2022, then decreased by 0.04% to -$45109.0 in 2023, then skyrocketed by 69.7% to -$13666.0 in 2024, then plummeted by 6304.24% to -$875203.0 in 2025.
  • Business Quant data shows EBIT for PAXH at -$875203.0 in Q3 2025, -$13463.0 in Q1 2025, and -$13666.0 in Q4 2024.